Report Detail
Global Tetanus Vaccine Market Professional Survey Report 2019
- RnM2932240 |
- 09 October, 2019 |
- Global |
- 102 Pages |
- QYResearch |
- Pharma & Healthcare
Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.
The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.
A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.
The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.
The global Tetanus Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Tetanus Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tetanus Vaccine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Tetanus Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Tetanus Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
GlaxoSmithKline plc
Pfizer,Inc
Merck & Co.,Inc
Sanofi Pasteur SA
Biological E
Dano Vaccine &Biological Pvt.Ltd.,
Panera
Shantha Biotechnics Ltd
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Diphtheria and tetanus (DT) vaccines
Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
Tetanus and diphtheria (Td) vaccines
Tetanus, diphtheria, and pertussis (Tdap) vaccines
Segment by Application
Adult
Pediatric
Table of Contents
Executive Summary
1 Industry Overview of Tetanus Vaccine
- 1.1 Definition of Tetanus Vaccine
- 1.2 Tetanus Vaccine Segment by Type
- 1.2.1 Global Tetanus Vaccine Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Diphtheria and tetanus (DT) vaccines
- 1.2.3 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
- 1.2.4 Tetanus and diphtheria (Td) vaccines
- 1.2.5 Tetanus, diphtheria, and pertussis (Tdap) vaccines
- 1.3 Tetanus Vaccine Segment by Applications
- 1.3.1 Global Tetanus Vaccine Consumption Comparison by Applications (2014-2025)
- 1.3.2 Adult
- 1.3.3 Pediatric
- 1.4 Global Tetanus Vaccine Overall Market
- 1.4.1 Global Tetanus Vaccine Revenue (2014-2025)
- 1.4.2 Global Tetanus Vaccine Production (2014-2025)
- 1.4.3 North America Tetanus Vaccine Status and Prospect (2014-2025)
- 1.4.4 Europe Tetanus Vaccine Status and Prospect (2014-2025)
- 1.4.5 China Tetanus Vaccine Status and Prospect (2014-2025)
- 1.4.6 Japan Tetanus Vaccine Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Tetanus Vaccine Status and Prospect (2014-2025)
- 1.4.8 India Tetanus Vaccine Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Tetanus Vaccine
- 2.3 Manufacturing Process Analysis of Tetanus Vaccine
- 2.4 Industry Chain Structure of Tetanus Vaccine
3 Development and Manufacturing Plants Analysis of Tetanus Vaccine
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Tetanus Vaccine Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Tetanus Vaccine
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Tetanus Vaccine Production and Capacity Analysis
- 4.2 Tetanus Vaccine Revenue Analysis
- 4.3 Tetanus Vaccine Price Analysis
- 4.4 Market Concentration Degree
5 Tetanus Vaccine Regional Market Analysis
- 5.1 Tetanus Vaccine Production by Regions
- 5.1.1 Global Tetanus Vaccine Production by Regions
- 5.1.2 Global Tetanus Vaccine Revenue by Regions
- 5.2 Tetanus Vaccine Consumption by Regions
- 5.3 North America Tetanus Vaccine Market Analysis
- 5.3.1 North America Tetanus Vaccine Production
- 5.3.2 North America Tetanus Vaccine Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Tetanus Vaccine Import and Export
- 5.4 Europe Tetanus Vaccine Market Analysis
- 5.4.1 Europe Tetanus Vaccine Production
- 5.4.2 Europe Tetanus Vaccine Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Tetanus Vaccine Import and Export
- 5.5 China Tetanus Vaccine Market Analysis
- 5.5.1 China Tetanus Vaccine Production
- 5.5.2 China Tetanus Vaccine Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Tetanus Vaccine Import and Export
- 5.6 Japan Tetanus Vaccine Market Analysis
- 5.6.1 Japan Tetanus Vaccine Production
- 5.6.2 Japan Tetanus Vaccine Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Tetanus Vaccine Import and Export
- 5.7 Southeast Asia Tetanus Vaccine Market Analysis
- 5.7.1 Southeast Asia Tetanus Vaccine Production
- 5.7.2 Southeast Asia Tetanus Vaccine Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Tetanus Vaccine Import and Export
- 5.8 India Tetanus Vaccine Market Analysis
- 5.8.1 India Tetanus Vaccine Production
- 5.8.2 India Tetanus Vaccine Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Tetanus Vaccine Import and Export
6 Tetanus Vaccine Segment Market Analysis (by Type)
- 6.1 Global Tetanus Vaccine Production by Type
- 6.2 Global Tetanus Vaccine Revenue by Type
- 6.3 Tetanus Vaccine Price by Type
7 Tetanus Vaccine Segment Market Analysis (by Application)
- 7.1 Global Tetanus Vaccine Consumption by Application
- 7.2 Global Tetanus Vaccine Consumption Market Share by Application (2014-2019)
8 Tetanus Vaccine Major Manufacturers Analysis
- 8.1 GlaxoSmithKline plc
- 8.1.1 GlaxoSmithKline plc Tetanus Vaccine Production Sites and Area Served
- 8.1.2 GlaxoSmithKline plc Product Introduction, Application and Specification
- 8.1.3 GlaxoSmithKline plc Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Pfizer,Inc
- 8.2.1 Pfizer,Inc Tetanus Vaccine Production Sites and Area Served
- 8.2.2 Pfizer,Inc Product Introduction, Application and Specification
- 8.2.3 Pfizer,Inc Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Merck & Co.,Inc
- 8.3.1 Merck & Co.,Inc Tetanus Vaccine Production Sites and Area Served
- 8.3.2 Merck & Co.,Inc Product Introduction, Application and Specification
- 8.3.3 Merck & Co.,Inc Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Sanofi Pasteur SA
- 8.4.1 Sanofi Pasteur SA Tetanus Vaccine Production Sites and Area Served
- 8.4.2 Sanofi Pasteur SA Product Introduction, Application and Specification
- 8.4.3 Sanofi Pasteur SA Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Biological E
- 8.5.1 Biological E Tetanus Vaccine Production Sites and Area Served
- 8.5.2 Biological E Product Introduction, Application and Specification
- 8.5.3 Biological E Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Dano Vaccine &Biological Pvt.Ltd.,
- 8.6.1 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Production Sites and Area Served
- 8.6.2 Dano Vaccine &Biological Pvt.Ltd., Product Introduction, Application and Specification
- 8.6.3 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Panera
- 8.7.1 Panera Tetanus Vaccine Production Sites and Area Served
- 8.7.2 Panera Product Introduction, Application and Specification
- 8.7.3 Panera Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Shantha Biotechnics Ltd
- 8.8.1 Shantha Biotechnics Ltd Tetanus Vaccine Production Sites and Area Served
- 8.8.2 Shantha Biotechnics Ltd Product Introduction, Application and Specification
- 8.8.3 Shantha Biotechnics Ltd Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of Tetanus Vaccine Market
- 9.1 Global Tetanus Vaccine Market Trend Analysis
- 9.1.1 Global Tetanus Vaccine Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Tetanus Vaccine Regional Market Trend
- 9.2.1 North America Tetanus Vaccine Forecast 2019-2025
- 9.2.2 Europe Tetanus Vaccine Forecast 2019-2025
- 9.2.3 China Tetanus Vaccine Forecast 2019-2025
- 9.2.4 Japan Tetanus Vaccine Forecast 2019-2025
- 9.2.5 Southeast Asia Tetanus Vaccine Forecast 2019-2025
- 9.2.6 India Tetanus Vaccine Forecast 2019-2025
- 9.3 Tetanus Vaccine Market Trend (Product Type)
- 9.4 Tetanus Vaccine Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Tetanus Vaccine Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Tetanus Vaccine . Industry analysis & Market Report on Tetanus Vaccine is a syndicated market report, published as Global Tetanus Vaccine Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Tetanus Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
